ResMed| vs Steris
ResMed| and Steris are similar in size: $5.65bn and $5.94bn of revenue in their latest fiscal years. ResMed| grew faster (9.9% against 8.7%). ResMed| kept more of each dollar of sales as profit: a net margin of 26.9% against 13.2%.
| Latest fiscal year | ResMed|RMD, 2026 | SterisSTE, 2026 |
|---|---|---|
| Revenue | $5.65bn | $5.94bn |
| Revenue growth | 9.9% | 8.7% |
| Net income | $1.52bn | $782m |
| Operating margin | — | 18.6% |
| Net margin | 26.9% | 13.2% |
| Return on equity | 24.3% | 11.3% |
| Free cash flow | $1.65bn | $972m |
| Cash | $1.47bn | $440m |
| Total debt | $659m | $1.93bn |
| Debt to equity | — | 26.9% |
| Dividend per share | $2.40 | $2.46 |
| Dividend yield | 1.1% | 1.1% |
| Share buybacks | $700m | $236m |
| Employees | 11,370 | 16,000 |
| Market value | $31.58bn | $22.58bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 88 (Strong) | 70 (Moderate) |
| Insider trades, 12 months | 0 buys, 32 sales | 0 buys, 12 sales |